Notice of Expiration of PA-13-042 "Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19)"

Notice Number: NOT-AI-14-030

Key Dates
Release Date: January 16, 2014

Related Announcements
PA-13-042

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice is to inform the scientific community that the National Institute of Allergy and Infectious Diseases (NIAID) is terminating immediately PA-13-042 "Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19)" because the NIH no longer supports paper submissions for this funding mechanism (U19).

Applications will not be accepted in response to PA-13-042. However, NIAID intends to issue an updated FOA that will utilize electronic submission.

Inquiries

Please direct all inquiries to:

Michael Pensiero, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-435-3749
Email: mpensiero@niaid.nih.gov  

 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.